Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Milena Jurisevic, Aleksandar Arsenijevic, Jelena Pantic, Nevena Gajovic, Jelena Milovanovic, Marija Milovanovic, Jelena Poljarevic, Tibor Sabo, Danilo Vojvodic, Gordana D. Radosavljevic, Nebojsa Arsenijevic
Published Jun 15, 2018 · Vol. 9, No. 46 · pp. 28195-28212
Güliz Acker, Sophie Käthe Piper, Anna Lena Datwyler, Thomas Broggini, Irina Kremenetskaia, Melina Nieminen-Kelhä, Janet Lips, Ulrike Harms, Susanne Mueller, Gilla Lättig-Tünnemann, Eveline Trachsel, Alessandro Palumbo, Dario Neri, Jan Klohs, Matthias Endres, Peter Vajkoczy, Christoph Harms, Marcus Czabanka
Published Jun 12, 2018 · Vol. 9, No. 45 · pp. 27760-27772
Ewa Rupniewska, Rajat Roy, Francesco A. Mauri, Xinxue Liu, Maciej Kaliszczak, Guido Bellezza, Lucio Cagini, Mattia Barbareschi, Stefano Ferrero, Anna M. Tommasi, Eric Aboagye, Michael J. Seckl, Olivier E. Pardo
Published Jun 8, 2018 · Vol. 9, No. 44 · pp. 27346-27362